GlaxoSmithKline Pharmaceuticals Ltd

BSE: 500660

2

total announcements

500660.BO · 15 min delayed

BSECompany UpdateMgmt Change1d ago

GlaxoSmithKline Pharmaceuticals Ltd

As per attachment

GlaxoSmithKline Pharmaceuticals Ltd has scheduled an analyst/institutional investor meeting on August 3rd, 2026, to share information already in the public domain.

Read more →📎 1 attachment
BSEBoard MeetingResults1d ago

GlaxoSmithKline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve approve and ....

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 03/08/2026 to consider and approve the un-audited financial results for the first quarter ended 30th June 2026.

Read more →📎 1 attachment